Phase I/II Study AC6 Gene Transfer for Congestive Heart Failure
Phase of Trial: Phase I/II
Latest Information Update: 01 Nov 2016
At a glance
- Drugs RT 100 (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 01 Nov 2016 According to a Renova Therapeutics media release, company has submitted trial results to the FDA.
- 30 Mar 2016 According to a Renova Therapeutics media release, results from this study will be published in the April 2016 print issue of JAMA Cardiology.
- 30 Mar 2016 Results were published in a Renova Therapeutics media release.